98634064 - SYNWEAVE

Information

• Trademark
• 98634064

• Source

• Serial Number

  98634064

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 05, 2024
  a year ago

• Transaction Date

  May 21, 2025
  a year ago

• Status Date

  May 08, 2025
  a year ago

• Location Date

  May 08, 2025
  a year ago

• Status Code

  661

• Current Location

  TMEG LAW OFFICE 107

  Employee Name

  DUBIN, DAVID

• Attorney Docket Number

  KUMAT0138US

  Attorney Name

  Lauren K. Tagarao

  Law Office Assigned Location Code

  L70

• Owners

  • SYNGENE INTERNATIONAL LTD

Case File Statements

• GS0401: Contract manufacturing and custom manufacture for biopharmaceutical companies for process development of manufacturing process of biologics being industrial chemicals in the fields of cell line development, clone selection, analytical methods, formulation, scale-up of the manufacturing process, manufacture of drug substance and drug product, viral testing, and viral clearance studies
• GS0051: Biological and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof, namely, biological preparations for use in cell cultures for medical purposes; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; protein dietary supplements; antibodies for medical purposes; synthetic peptides for pharmaceutical purposes for the treatment of cancer, infectious diseases, disorder related to central nervous system, immunology, ophthalmology, respiratory, gastrointestinal, cardiovascular dermatology related disorders, metabolic disorders and musculoskeletal disorders; nucleic acid sequences and biochemical reagents both for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biopharmaceutical preparations for the treatment of cancer; cells for medical use, viral vector vaccines, and protein supplements for medical use; medicines for veterinary purposes being medicinal preparations for the treatment of disorders related to cancer, immune system, neuroscience, inflammation, coronary microvascular dysfunction, metabolic disorders and parasitic indications; biological preparations for use in cell cultures for medical purposes; biochemical reagents for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, recombinant proteins being buffers, and nucleic acids being reagents for use in disease testing
• GS0011: Chemicals for use in biotechnological product development in the fields of mammalian cells, antibodies, proteins, carbohydrates, enzymes, lipids, nucleic acids, DNA products, immunological re-agents, and biochemicals being organic intermediates; active biochemical ingredients, namely, industrial chemicals for use in the manufacture of biopharmaceuticals for treating diseases and conditions; biochemicals for industrial use being industrial chemicals; assays for research purposes; biomedical compounds, namely, industrial chemicals for use in the fields of antibodies, recombinant proteins, antibodies, protein carbohydrates, enzymes, lipids, and nucleic acids, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; biochemical polymers being unprocessed polymers; biochemicals being industrial chemicals for use in biotechnological product development; proteins for use in manufacturing; cells for scientific, laboratory or medical research; chemical reagents, other than for medical or veterinary purposes for use in the development of antibodies, proteins, and nucleic acids; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; protein arrays and nucleotide arrays for scientific and medical research; peptides for industrial purposes being industrial chemicals; protein for industrial use for use in recombinant DNA technology; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; reference standards being industrial chemicals for use in science and industry; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology
• GS0441: Services for creating scientific research and development of process and products relating to medical diagnostic testing and monitoring.
• GS0421: Scientific research and development for biopharmaceutical companies in the field of biologics being antibodies, proteins, cells, and nucleic acids; custom design and development of chemical regents and biochemical assays being biochemicals and biopharmaceuticals; laboratory testing of materials; laboratory testing of materials services; testing of pharmaceuticals; biochemical engineering; biopharmaceutical drug development services being pharmaceutical drug development services; biopharmaceutical products development being research and development of new products; biopharmaceutical substance and products manufacturing being research and development of new products; development of pharmaceutical preparations and medicines; scientific study and research in the fields of reproduction, husbandry, and general health of animal; biotechnology research being scientific research for determining the neuronal survival of molecules in animal models; scientific research and development services in the fields of proteins, antibodies, antibody technology; custom design and development of biochemical reagents being chemical reagents and biochemical assays; design, engineering, research, development and testing services of new products for others in the fields of biochemicals, materials customization for medical, scientific, and technological applications; viral testing services being product quality testing services; viral testing analysis being chemical analysis; toxicity testing for research purposes being chemical analysis; conducting and providing tests being chemical analysis and supporting analysis for clinical trials being chemical analysis; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; scientific research being analytical services for scientific research purposes; laboratory research in the field of chemistry being protein expression; scientific research services relating to the isolation and cultivation of human tissues and cells; scientific research being preparation of reports relating to scientific and technical research; scientific research being analysis in the field of molecular biology; scientific research being contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific laboratory services; services of a chemical and biological laboratory being scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific research and development and scientific research consultation in the fields of antibodies, antibody technology, chemistry, bioinformatics, biomedical, biologics, biotechnology, biotherapeutics, biology, biochemical, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, and ophthalmic; scientific and technological services, namely, scientific research, scientific development, analysis, testing, engineering, extraction being scientific development, synthesis being scientific development, purification being scientific development, and production being scientific development in the fields of antibody, application programming interfaces, biomolecules, cell bank characterization, chiral, chromosome aberration, clinical chemistry, cloning vector, DNA, flow cytometry, mass spectrometry, gene, immuno-pharmaceuticals, in vitro assays, large molecule, liquid chromatography mass spectrometry, microbial, monomer, nanoparticle, natural products, peptides, proteins, RNA, supercritical fluid chromatography, and vaccines

Case File Event Statements

• 7/5/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/18/2024 - a year ago

  4 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 10/18/2024 - a year ago

  3 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/18/2024 - a year ago

  5 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/18/2024 - a year ago

  2 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 10/18/2024 - a year ago

  6 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 1/14/2025 - a year ago

  9 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/1/2025 - a year ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/4/2024 - a year ago

  7 - ASSIGNED TO LIE Type: ALIE

• 12/4/2024 - a year ago

  8 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 1/22/2025 - a year ago

  10 - ASSIGNED TO EXAMINER Type: DOCK

• 2/1/2025 - a year ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/1/2025 - a year ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/1/2025 - a year ago

  14 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 5/1/2025 - a year ago

  15 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 5/8/2025 - a year ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/8/2025 - a year ago

  16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/8/2025 - a year ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/14/2025 - a year ago

  21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/14/2025 - a year ago

  19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 5/14/2025 - a year ago

  20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA